1990-2016年北欧国家皮肤恶性黑色素瘤患者的生存趋势:NORDCAN生存研究
该研究基于NORDCAN数据库识别1990-2016年北欧国家诊断为皮肤恶性黑色素瘤的患者,采用灵活参数相对生存模型(冰岛用非参数Pohar-Perme法),按性别估计年龄标准化及年龄别生存指标。结果显示所有国家男女及各年龄组5年相对生存率均改善,男性改善更明显但女性生存仍更高,研究末期年龄标准化5年相对生存率从冰岛男性85%至丹麦女性95%。
要点
- 所有北欧国家男女及各年龄组皮肤恶性黑色素瘤5年相对生存率均改善。
- 男性生存改善幅度更明显,但研究末期女性生存仍高于男性。
- 研究末期年龄标准化5年相对生存率从冰岛男性85%至丹麦女性95%。
核心结论
- 尽管1990年北欧国家皮肤恶性黑色素瘤生存已相对较高,研究期间男女及各年龄组生存持续改善。
研究设计与样本
- 基于NORDCAN数据库识别1990-2016年北欧国家诊断为皮肤恶性黑色素瘤的患者。
- 采用灵活参数相对生存模型,冰岛采用非参数Pohar-Perme法。
- 按性别估计年龄标准化及年龄别的一系列生存指标。
主要发现
- 所有国家男女及各年龄组5年相对生存率均改善,男性改善更明显但女性研究末期生存仍更高。
- 研究末期年龄标准化5年相对生存率从冰岛男性85%至丹麦女性95%。
- 年龄标准化及参照调整的5年皮肤恶性黑色素瘤 crude 死亡概率从丹麦和瑞典女性5%至冰岛男性13%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements are observed in all ages and for both women and men. METHODS: Patients diagnosed with CMM in the Nordic countries in 1990-2016 were identified in the NORDCAN database. Flexible parametric relative survival models were fitted, except for Iceland where a non-parametric Pohar-Perme approach was used. A range of survival metrics were estimated by sex, both age-standardised and age-specific. RESULTS: The 5-year relative survival improved in all countries, in both women and men and across age. While the improvement was more pronounced in men, women still had a higher survival at the end of the study period. The survival was generally high, with age-standardised estimates of 5-year relative survival towards the end of the study period ranging from 85% in Icelandic men to 95% in Danish women. The age-standardised and reference-adjusted 5-year crude probability of death due to CMM ranged from 5% in Danish and Swedish women to 13% in Icelandic men. CONCLUSION: Although survival following CMM was relatively high in the Nordic countries in 1990, continued improvements in survival were observed throughout the study period in both women and men and across age.
引用
- Lundberg FE, Birgisson H, Engholm G, et al. Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies. Eur J Cancer. 2024. PMID: 38452724. doi:10.1016/j.ejca.2024.113980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。